Insight Molecular Diagnostics (IMDX) Cost of Revenue (2016 - 2026)
Insight Molecular Diagnostics (IMDX) posted Cost of Revenue of $17000.0 for Q1 2026, up 100.74% sequentially from -$2.3 million in Q4 2025, and down 98.59% YoY from $1.2 million in Q1 2025.
Insight Molecular Diagnostics (IMDX) Cost of Revenue (2016 - 2026) Analysis & Trends
Insight Molecular Diagnostics (IMDX) has 11 years of Cost of Revenue data on file, last reported at $17000.0 in Q1 2026.
- Quarterly Cost of Revenue fell 98.59% year-over-year to $17000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$731000.0 (down 79.17% YoY) and the FY2025 annual result came in at $1.8 million, up 66.19% from the prior year.
- Cost of Revenue rose to $17000.0 in Q1 2026 per IMDX's latest filing, from -$2.3 million in the prior quarter.
- The five-year high for Cost of Revenue was $1.4 million in Q3 2025, with the low at -$2.3 million in Q4 2025.
- Average Cost of Revenue over 5 years is $84764.7, with a median of $168000.0 recorded in 2025.
- Year-over-year, Cost of Revenue sank 512.96% in 2024 and surged 3123.26% in 2025.
- Insight Molecular Diagnostics' Cost of Revenue stood at $278000.0 in 2022, then jumped by 47.12% to $409000.0 in 2023, then slumped by 512.96% to -$1.7 million in 2024, then plunged by 36.29% to -$2.3 million in 2025, then surged by 100.74% to $17000.0 in 2026.
- Business Quant data shows IMDX's Cost of Revenue at $17000.0 in Q1 2026, -$2.3 million in Q4 2025, and $1.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 155.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 3.26 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 2.36 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 175.25 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 608,000.00 |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 845.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 2.80 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 370.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 118.74 Mn |
| 10 | Insight Molecular Diagnostics | 196.41 Mn | 167.48 Mn | 15,000.00 | 17,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17,000.00 |
| Mar 31, 2026 | 17,000.00 |
| Dec 31, 2025 | -2.30 Mn |
| Dec 31, 2025 | -2.30 Mn |
| Sep 30, 2025 | 1.39 Mn |
| Sep 30, 2025 | 1.39 Mn |
| Jun 30, 2025 | 168,000.00 |
| Jun 30, 2025 | 168,000.00 |
| Mar 31, 2025 | 1.21 Mn |
| Mar 31, 2025 | 1.21 Mn |
| Dec 31, 2024 | -1.69 Mn |
| Dec 31, 2024 | -1.69 Mn |
| Sep 30, 2024 | 43,000.00 |
| Sep 30, 2024 | 43,000.00 |
| Jun 30, 2024 | 32,000.00 |
| Jun 30, 2024 | 32,000.00 |
| Mar 31, 2024 | 109,000.00 |
| Mar 31, 2024 | 109,000.00 |
| Dec 31, 2023 | 409,000.00 |
| Dec 31, 2023 | 409,000.00 |